SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: Jim Roof who wrote (917)11/19/1998 3:41:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
What's ironic is that VICL also has items in late phase trials. Geron & Entremed zoomed much higher on announcements items in pre-clinical. ISIP gets an FDA approval on the first ever antisense med & it gets little response. I thought once of the principles of good biotech investing was to center on companies with multiple items in phase II/or III testing. Oh Well. Scott